Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA)

CUSIP: 877619106

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
275,000,000
Total 13F shares
167,381,791
Share change
+11,306,475
Total reported value
$289,604,775
Put/Call ratio
16%
Price per share
$1.73
Number of holders
126
Value change
+$18,983,312
Number of buys
66
Number of sells
42

Quarterly Holders Quick Answers

What is CUSIP 877619106?
CUSIP 877619106 identifies TSHA - Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) as of Q4 2024

As of 31 Dec 2024, Taysha Gene Therapies, Inc. - Common Stock, par value $0.00001 per share (TSHA) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 167,381,791 shares. The largest 10 holders included Avoro Capital Advisors LLC, MORGAN STANLEY, FMR LLC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., Octagon Capital Advisors LP, VANGUARD GROUP INC, RTW INVESTMENTS, LP, Siren, L.L.C., and STATE STREET CORP. This page lists 127 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.